Observing eye disease progression in type 2 diabetes
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study closely follows people with type 2 diabetes who have early signs of diabetic retinopathy (damage to the retina from diabetes) to see how the condition changes over time. It does not test a new treatment but monitors the eye's health closely. It may be a good fit if you have diabetic retinopathy that does not need immediate treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes, as defined by standard medical criteria.
- You are between 35 and 80 years old.
- Your vision is good (equivalent to at least 20/40 with glasses or contacts).
- You have a specific, early stage of diabetic retinopathy that does not need immediate laser or injection therapy.
- You have not had prior laser treatment (panretinal photocoagulation) or injections in the eye for retinopathy.
- You have not had eye surgery in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at medical records of people with type 2 diabetes to understand how diabetic eye disease (retinopathy) progresses and when treatment is needed. It may help doctors better predict risks and guide future care.
This study uses special eye photographs to look at early signs of diabetes damage in the eyes and kidneys. It may help doctors predict how diabetes complications progress and plan better care.
This study is testing a better way to diagnose and manage eye problems (diabetic retinopathy) in people with type 2 diabetes. It aims to improve how doctors find and treat these issues to help protect your vision.
This program aims to screen people for diabetic eye problems early and help prevent vision loss over time. It may help you if you have type 2 diabetes (or you’ve been invited as a diabetes/non-diabetes participant) and can safely take part in the study activities.
This study looks for specific eye findings (“biomarkers”) in people with type 2 diabetes using eye imaging. It may help researchers better understand diabetic retinopathy and how to detect it earlier or more accurately.
This study tests a new approach aimed at improving diabetic eye disease (diabetic retinopathy). It may help by changing inflammation and related processes in the eye, especially in people who have diabetes and eye changes.
Hear when a new Diabetic Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.